Sun Pharma Advanced Research Company Ltd.

BSE: 532872 | NSE: SPARC |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE232I01014 | SECTOR: Biotechnology & Medical ResearchBiotechnology & Medical Research

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Sun Pharma Adv Sun Pharma Advanced Research Company Ltd. | BSE 148.80 -2.90 (-1.91%) | NSE 148.97 -2.58 (-1.70%) | Trade | Add

BSE Live

Dec 04, 13:27

148.80 -2.90 (-1.91%)

Volume

AVERAGE VOLUME

5-Day

3,452,876

10-Day

1,757,834

30-Day

641,158

5,889,987

Prev. Close

151.70
Open Price

151.90

Bid Price (Qty.)
148.75 (218)
Offer Price (Qty.)
148.90 (862)

NSE Live

Dec 04, 13:27

148.97 -2.58 (-1.70%)

Volume

AVERAGE VOLUME

5-Day

29,682,354

10-Day

15,300,766

30-Day

5,528,328

41,145,389

Prev. Close

151.55
Open Price

152.00

Bid Price (Qty.)
148.86 (276)
Offer Price (Qty.)
148.97 (44)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Sun Pharma Advanced Research Company (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	71.77	75.55	238.78	137.25	252.96
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	71.77	75.55	238.78	137.25	252.96
Total Operating Revenues	71.77	75.55	238.78	137.25	252.96
Other Income	1.79	29.47	10.88	6.84	5.41
Total Revenue	73.56	105.01	249.66	144.09	258.37
EXPENSES
Cost Of Materials Consumed	23.12	28.13	22.11	18.27	18.18
Purchase Of Stock-In Trade	0.00	0.00	0.00	0.00	0.00
Operating And Direct Expenses	222.59	280.24	281.41	179.28	247.40
Changes In Inventories Of FG,WIP And Stock-In Trade	0.00	0.00	0.00	0.00	0.00
Employee Benefit Expenses	108.96	118.53	107.00	96.78	91.59
Finance Costs	8.91	1.66	7.63	13.33	10.65
Depreciation And Amortisation Expenses	10.83	12.13	11.77	10.16	10.92
Other Expenses	44.37	52.44	42.31	29.67	30.77
Total Expenses	418.78	493.12	472.24	347.49	409.51
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	-345.22	-388.11	-222.58	-203.40	-151.14
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	-345.22	-388.11	-222.58	-203.40	-151.14
Tax Expenses-Continued Operations
Current Tax	0.00	0.00	0.00	0.00	0.00
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	0.00	0.00	0.00	0.00	0.00
Profit/Loss After Tax And Before ExtraOrdinary Items	-345.22	-388.11	-222.58	-203.40	-151.14
Profit/Loss From Continuing Operations	-345.22	-388.11	-222.58	-203.40	-151.14
Profit/Loss For The Period	-345.22	-388.11	-222.58	-203.40	-151.14
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	-10.64	-11.96	-7.82	-7.73	-5.77
Diluted EPS (Rs.)	-10.64	-11.96	-7.82	7.73	-5.77
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	0.00	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	0.00	0.00	0.00	0.00	0.00